The effect of oral N-acetylcysteine on serum high sensitive CRP and plasma hemoglobin levels in end-stage renal disease patients under routine hemodialysis; a randomized placebocontrolled clinical trial

The effect of oral N-acetylcysteine on serum high sensitive CRP and plasma hemoglobin levels in end-stage renal disease patients under routine hemodialysis; a randomized placebocontrolled clinical trial

Background: Oxidative stress and systemic inflammation is increased in end-stage renal disease (ESRD) patients. Due to the various effects of oxidative stress in ESRD patients, different antioxidants have been evaluated. Objectives: In this study, we evaluated the effect of oral N-acetylcysteine (NA...

Full description

Bibliographic Details
Main Authors: Bahman Bashardoust, Roya Alaei, Sousan Mohammadi Kebar, Sabah Hasani, Afshin Habibzadeh
Format: Article
Language:English
Published: Society of Diabetic Nephropathy Prevention 2018-10-01
Series:Journal of Nephropathology
Subjects:
end-stage renal disease
high sensitivity crp
n-acetylcysteine
hemoglobin
Online Access:https://nephropathol.com/PDF/jnp-7-268.pdf

Internet

https://nephropathol.com/PDF/jnp-7-268.pdf

Similar Items